Craig Fraser Windtree Therapeutics Inc (WINT) insider trading activity

Craig Fraser is President and CEO of WINDTREE THERAPEUTICS INC . Currently has a direct ownership of 57,877 shares of WINT, which is worth approximately $184,048. The most recent transaction as insider was on Sep 27, 2023, when has been sold 2,500 shares (Common Stock) at a price of $1.02 per share, resulting in proceeds of $2,550. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.9K

0% 3M change

725.63% 12M change

Total Value Held $184,048

Craig Fraser Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 27 2023	BUY Open market or private purchase	$2,550 $1.02 p/Share	2,500 Added 4.14%	57,877 Common Stock
Sep 26 2023	BUY Open market or private purchase	$2,250 $0.9 p/Share	2,500 Added 4.32%	55,377 Common Stock
Aug 23 2023	BUY Grant, award, or other acquisition	-	45,867 Added 46.45%	52,877 Common Stock
Apr 26 2023	BUY Open market or private purchase	$2,649 $1.77 p/Share	1,497 Added 17.6%	7,010 Common Stock
Apr 25 2023	BUY Open market or private purchase	$2,485 $1.89 p/Share	1,315 Added 19.26%	5,513 Common Stock
Feb 28 2023	SELL Payment of exercise price or tax liability	-	334 Reduced 7.37%	4,198 Common Stock
Jul 27 2022	BUY Open market or private purchase	$950 $0.38 p/Share	2,500 Added 1.09%	226,558 Common Stock

Jul 26 2022	BUY Open market or private purchase	$925 $0.37 p/Share	2,500 Added 1.1%	224,058 Common Stock
Jun 30 2022	BUY Open market or private purchase	$1,935 $0.43 p/Share	4,500 Added 1.99%	221,558 Common Stock
Jun 29 2022	BUY Open market or private purchase	$2,940 $0.42 p/Share	7,000 Added 3.12%	217,058 Common Stock
Mar 16 2022	BUY Open market or private purchase	$1,960 $0.98 p/Share	2,000 Added 0.94%	210,058 Common Stock
Mar 15 2022	BUY Open market or private purchase	$2,940 $0.98 p/Share	3,000 Added 1.42%	208,058 Common Stock
Mar 04 2022	BUY Grant, award, or other acquisition	-	166,900 Added 44.87%	205,058 Common Stock
Nov 19 2021	BUY Open market or private purchase	$1,488 $1.6 p/Share	930 Added 2.38%	38,158 Common Stock
Nov 18 2021	BUY Open market or private purchase	$1,497 $1.61 p/Share	930 Added 2.44%	37,228 Common Stock
Oct 22 2021	BUY Open market or private purchase	$5,700 $1.9 p/Share	3,000 Added 7.63%	36,298 Common Stock
Oct 19 2021	BUY Open market or private purchase	$5,730 $1.91 p/Share	3,000 Added 8.26%	33,298 Common Stock
Apr 16 2021	BUY Open market or private purchase	$2,090 $2.09 p/Share	1,000 Added 3.2%	30,298 Common Stock
Apr 15 2021	BUY Open market or private purchase	$2,240 $2.24 p/Share	1,000 Added 3.3%	29,298 Common Stock
Apr 06 2021	BUY Open market or private purchase	$1,285 $2.57 p/Share	500 Added 1.74%	28,298 Common Stock
Apr 05 2021	BUY Open market or private purchase	$2,580 $2.58 p/Share	1,000 Added 3.47%	27,798 Common Stock
Apr 01 2021	BUY Open market or private purchase	$1,230 $2.46 p/Share	500 Added 1.83%	26,798 Common Stock
Mar 31 2021	BUY Open market or private purchase	$1,160 $2.32 p/Share	500 Added 1.87%	26,298 Common Stock
Mar 25 2021	BUY Open market or private purchase	$4,875 $3.25 p/Share	1,500 Added 5.49%	25,798 Common Stock
Oct 28 2020	BUY Open market or private purchase	$1,640 $6.56 p/Share	250 Added 1.02%	24,298 Common Stock

Craig Fraser

President and CEO

Warrington, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells WINT shares.

Notify only if

Value

Insider Trading

Get notified when an Windtree Therapeutics Inc insider buys or sells WINT shares.

Notify only if

Operation

Value

Type

News

Receive news related to WINDTREE THERAPEUTICS INC

Track Activities on WINT

Account